Wilshire Advisors Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
loanDepot
LDI
|
+$12.7M |
| 2 |
Fate Therapeutics
FATE
|
+$9.15M |
| 3 |
iShares Core US Aggregate Bond ETF
AGG
|
+$1.19M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P Small-Cap ETF
IJR
|
+$1.46M |
| 2 |
iShares Core MSCI EAFE ETF
IEFA
|
+$233K |
| 3 |
iShares Core MSCI Emerging Markets ETF
IEMG
|
+$85.3K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 43.95% |
| 2 | Miscellaneous | 28.34% |
| 3 | Healthcare | 27.71% |
Similar funds
Wilshire Advisors's Q3 2025 Portfolio in Review
As of Q3 2025, Wilshire Advisors held 7 positions worth $38.6M, up 249% from $11.1M the previous quarter. Its ten largest holdings account for 100% of the portfolio.
Wilshire Advisors deployed $21.3M of net new capital in Q3 2025, opening 1 new position and adding to 2 existing holdings. Its largest new stake was Fate Therapeutics: 8,486,822 shares worth $10.7M.
By sector, the portfolio is most concentrated in Financials at 44% of assets, up from 0.32% a quarter earlier, followed by Miscellaneous and Healthcare.
On the sell side, the largest reduction was iShares Core S&P Small-Cap ETF, an estimated $1.46M trimmed.
- Wilshire Advisors's largest Q3 2025 buy was Fate Therapeutics: 8,486,822 shares worth $10.7M.
- Wilshire Advisors added most to loanDepot in Q3 2025, an estimated $12.7M increase.
- Wilshire Advisors's biggest Q3 2025 reduction was iShares Core S&P Small-Cap ETF, cutting an estimated $1.46M.
- Wilshire Advisors's ten largest holdings make up 100% of its $38.6M portfolio in Q3 2025.
- Wilshire Advisors opened 1 new position and closed 0 in Q3 2025.
- Wilshire Advisors's portfolio value rose 249% quarter-over-quarter to $38.6M.
Based on Wilshire Advisors's 13F filing for Q3 2025, filed 14 Nov 2025.